ESPEN practical guideline: Clinical nutrition in liver disease

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836

Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)

McClave, S. A., Taylor, B. E., Martindale, R. G., Warren, M. M., Johnson, D. R., Braunschweig, C., McCarthy, M. S., Davanos, E., Rice, T. W., Cresci, G. A., et al. (2016) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115621863 · Cited by 3,982

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327

Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

Vernon, G. C., Baranova, A. V., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,116

Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials

KONDRUP, J. (2003) · Clinical Nutrition · doi:10.1016/s0261-5614(02)00214-5 · Cited by 3,063

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987

Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis

Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492

ESPEN guideline: Clinical nutrition in surgery

Weimann, A., Braga, M., Carli, F., Higashiguchi, T., Hübner, M., Kłęk, S., Laviano, A., Ljungqvist, O. H., Lobo, D. N., Martindale, R. G., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.02.013 · Cited by 1,978

The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,805

Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans

Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765

Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review

Chan, W.-K., Chuah, K.-H., Rajaram, R. B., Lim, L.-L., Ratnasingam, J., & Vethakkan, S. R. (2023) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes23052 · Cited by 776

EASL Clinical Practice Guidelines on acute-on-chronic liver failure

Moreau, R., Tonon, M., Krag, A. A., Angeli, P., Berenguer, M., Berzigotti, A., Fernández, J., Francoz, C., Gustot, T., Jalan, R., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.021 · Cited by 386

ACG Clinical Guideline: Alcohol-Associated Liver Disease

Jophlin, L., Singal, A. K., Bataller, R. A., Wong, R. J., Sauer, B. G., Terrault, N. A., & Shah, V. H. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002572 · Cited by 319

Non-alcoholic fatty liver disease: A patient guideline

Francque, S. M., Marchesini, G., Kautz, A., Walmsley, M., Dorner, R., Lazarus, J. V., Zelber-Sagi, S., Hallsworth, K., Busetto, L., Frühbeck, G., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100322 · Cited by 264

Acute Liver Failure Guidelines

Shingina, A., Mukhtar, N. A., Wakim-Fleming, J., Alqahtani, S. A., Wong, R. J., Limketkai, B. N., Larson, A. M., & Grant, L. M. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002340 · Cited by 240

Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease

Ma, Y., Lee, G., Heo, S.-Y., & Roh, Y. (2021) · Antioxidants · doi:10.3390/antiox11010091 · Cited by 233

Western diets and chronic diseases

Adolph, T. E., & Tilg, H. (2024) · Nature Medicine · doi:10.1038/s41591-024-03165-6 · Cited by 224

Parenteral Nutrition Overview

Berlana, D. (2022) · Nutrients · doi:10.3390/nu14214480 · Cited by 192

AASLD Practice Guidance on Acute-on-chronic liver failure and the management of critically ill patients with cirrhosis

Karvellas, C. J., Bajaj, J. S., Kamath, P. S., Napolitano, L. M., O’Leary, J. G., Solà, E., Subramanian, R., Wong, F. S.-H., & Asrani, S. K. (2023) · Hepatology · doi:10.1097/hep.0000000000000671 · Cited by 176

Diet-Derived Antioxidants and Their Role in Inflammation, Obesity and Gut Microbiota Modulation

Deledda, A., Annunziata, G., Tenore, G. C., Palmas, V., Manzin, A., & Velluzzi, F. (2021) · Antioxidants · doi:10.3390/antiox10050708 · Cited by 163

Influence of the nutritional status and oxidative stress in the desaturation and elongation of n-3 and n-6 polyunsaturated fatty acids: Impact on non-alcoholic fatty liver disease

Videla, L. A., Hernández‐Rodas, M. C., Metherel, A. H., & Valenzuela, R. (2022) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2022.102441 · Cited by 148

Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges

Petroni, M. L., Brodosi, L., Marchignoli, F., Sasdelli, A. S., Caraceni, P., Marchesini, G., & Ravaioli, F. (2021) · Nutrients · doi:10.3390/nu13082748 · Cited by 116

Is ChatGPT an Effective Tool for Providing Dietary Advice?

Ponzo, V., Goitre, I., Favaro, E., Merlo, F. D., Mancino, M. V., Riso, S., & Bo, S. (2024) · Nutrients · doi:10.3390/nu16040469 · Cited by 100

Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Houttu, V., Csader, S., Nieuwdorp, M., Holleboom, A. G., & Schwab, U. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.716783 · Cited by 104

Positive Effects of Exercise Intervention without Weight Loss and Dietary Changes in NAFLD-Related Clinical Parameters: A Systematic Review and Meta-Analysis

Babu, A. F., Csader, S., Lok, J., Gómez-Gallego, C., Hanhineva, K., El-Nezami, H. S., & Schwab, U. (2021) · Nutrients · doi:10.3390/nu13093135 · Cited by 102

Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis

Cola, S. D., D’Amico, G., Caraceni, P., Schepis, F., Loredana, S., Lampertico, P., Toniutto, P., Martini, S., Maimone, S., Colecchia, A., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.05.020 · Cited by 72

Acute liver failure: A practical update

Fernández, J., Bassegoda, O., Toapanta, D., & Bernal, W. E. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101131 · Cited by 76

Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility

Mambrini, S. P., Grillo, A., Colosimo, S., Zarpellon, F., Pozzi, G., Furlan, D., Amodeo, G., & Bertoli, S. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1426551 · Cited by 70

Current Medical Treatment for Alcohol-Associated Liver Disease.

Ayares, G., Idalsoaga, F., Díaz, L., Arnold, J., & Arab, J. (2022) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.02.001 · Cited by 61

Liver transplantation in the patient with physical frailty

Tandon, P., Zanetto, A., Piano, S. S., Heimbach, J. K., & Dasarathy, S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.025 · Cited by 64

Acute liver failure

Vasques, F., Cavazza, A., & Bernal, W. (2022) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000923 · Cited by 64

Nutritional Support for Alcoholic Liver Disease

Tadokoro, T., Morishita, A., Himoto, T., & Masaki, T. (2023) · Nutrients · doi:10.3390/nu15061360 · Cited by 66

Efficacy of branched chain amino acids supplementation in liver cirrhosis: A systematic review and meta-analysis

Konstantis, G., Pourzitaki, C., Chourdakis, M., Kitsikidou, E., & Germanidis, G. S. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.03.027 · Cited by 59

Impact of Sarcopenia on Survival and Clinical Outcomes in Patients With Liver Cirrhosis

Topan, M.-M., Sporea, I., Danilă, M., Popescu, A., Ghiuchici, A.-M., Lupușoru, R., & Șirli, R. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.766451 · Cited by 51

Anemia in cirrhosis: An underestimated entity

Manrai, M., Dawra, S., Kapoor, R., Srivastava, S., & Singh, A. K. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i3.777 · Cited by 55

Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement

Boursier, J., Anty, R., Carette, C., Cariou, B., Castéra, L., Caussy, C., Fontaine, H., Garioud, A., Gourdy, P., Guerci, B., et al. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101272 · Cited by 51

Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective

Díaz, L. A., König, D., Weber, S., Ayares, G., Fuentealba, J. M., Vázquez, V., Bataller, R. A., Kamath, P. S., Winder, G. S., Leggio, L., et al. (2025) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(24)00380-7 · Cited by 51

Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?

Gudan, A., Kozłowska‐Petriczko, K., Wunsch, E., Bodnarczuk, T., & Stachowska, E. (2023) · Nutrients · doi:10.3390/nu15061323 · Cited by 55

Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers

Basu, R., Noureddin, M., & Clark, J. M. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.04.005 · Cited by 45

Can Nutrition Contribute to a Reduction in Sarcopenia, Frailty, and Comorbidities in a Super-Aged Society?

Yoshida, S., Shiraishi, R., Nakayama, Y., & Taira, Y. (2023) · Nutrients · doi:10.3390/nu15132991 · Cited by 47

The Role of Sarcopenia and Myosteatosis in Short- and Long-Term Outcomes Following Curative-Intent Surgery for Hepatocellular Carcinoma in a European Cohort

Meister, F., Lurje, G., Verhoeven, S., Wiltberger, G. J., Heij, L. R., Liu, W., Jiang, D., Bruners, P., Lang, S. A., Ulmer, T. F., et al. (2022) · Cancers · doi:10.3390/cancers14030720 · Cited by 43

Early Diagnosis and Prevention of Infections in Cirrhosis

Kulkarni, A. V., Premkumar, M., Arab, J. P., Kumar, K., Sharma, M., Reddy, D. N., Padaki, N. R., & Reddy, K. R. (2022) · Seminars in Liver Disease · doi:10.1055/a-1869-7607 · Cited by 44

Enteral nutrition product formulations: A review of available products and indications for use

Church, A., & Zoeller, S. (2023) · Nutrition in Clinical Practice · doi:10.1002/ncp.10960 · Cited by 39

Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases

Espina, S., Deza, D. C., Monterde, V. B., Domper-Arnal, M. J., García, S. G., & Luè, A. (2023) · Nutrients · doi:10.3390/nu15153487 · Cited by 43

[ESPEN Practical Guideline: Clinical nutrition in liver disease].

Bischoff, S., Bernal, W., Dasarathy, S., Merli, M., Plank, L., Schütz, T., Plauth, M., Peláez, R. B., & Irigoín, R. R. (2022) · Nutrición Hospitalaria · doi:10.20960/nh.03856 · Cited by 17

Usefulness of the Global Leadership Initiative on Malnutrition criteria to predict sarcopenia and mortality in patients with chronic liver disease

Miwa, T., Hanai, T., Nishimura, K., Unome, S., Maeda, T., Ogiso, Y., Imai, K., Suetsugu, A., Takai, K., & Shimizu, M. (2022) · Hepatology Research · doi:10.1111/hepr.13816 · Cited by 39

Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties

Marrone, G., Serra, A., Miele, L., Biolato, M., Liguori, A., Grieco, A., & Gasbarrini, A. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i19.2905 · Cited by 35

Sarcopenia in Chronic Liver Disease: A Metabolic Perspective

Kumar, R. K., Prakash, S. S., Priyadarshi, R. N., & Anand, U. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00239 · Cited by 37

Compensated liver cirrhosis: Natural course and disease-modifying strategies

Kumar, R. K., Kumar, S., & Prakash, S. S. (2023) · World Journal of Methodology · doi:10.5662/wjm.v13.i4.179 · Cited by 40

From liver to hormones: The endocrine consequences of cirrhosis

Aldave, J. E. Q., Osorio, E. R. G., Durand‐Vásquez, M. D. C., Rafael-Robles, L. D. P., Yovera, J. G. G., Quispe-Flores, M. A., Urteaga, L. A. C., Román-Gonzaléz, A., Paz‐Ibarra, J., & Concepción‐Zavaleta, M. J. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i9.1073 · Cited by 39

Nutrition and Chronic Liver Disease

de la Fuente, R. A. (2022) · Clinical Drug Investigation · doi:10.1007/s40261-022-01141-x · Cited by 34

Fibroblast Growth Factors for Nonalcoholic Fatty Liver Disease: Opportunities and Challenges

Tian, H., Zhang, S., Liu, Y., Wu, Y., & Zhang, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054583 · Cited by 33

Definition of Sarcopenia in Chronic Liver Disease

Son, S. W., Song, D. S., Chang, U. I., & Yang, J. M. (2021) · Life · doi:10.3390/life11040349 · Cited by 32

Association of Serum Albumin Levels and Long-Term Prognosis in Patients with Biopsy-Confirmed Nonalcoholic Fatty Liver Disease

Takahashi, K., Kawanaka, M., Fujii, H., Iwaki, M., Hayashi, H., Toyoda, H., Oeda, S., Hyogo, H., Morishita, A., Munekage, K., et al. (2023) · Nutrients · doi:10.3390/nu15092014 · Cited by 33

Body composition and the skeletal muscle compartment in liver transplantation: Turning challenges into opportunities

Reichelt, S., Pratschke, J., Engelmann, C., Neumann, U. P., Lurje, G., & Czigány, Z. (2022) · American Journal of Transplantation · doi:10.1111/ajt.17089 · Cited by 32

Branched‐chain amino acid supplementation does not improve measures of sarcopenia in cirrhosis: results of a randomised controlled trial

Hey, P., Hoermann, R., Sinclair, M. J., Chapman, B., Testro, A., Apostolov, R., Angus, P., & Gow, P. J. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17917 · Cited by 28

Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial

Mogna-Peláez, P., Riezu‐Boj, J. I., Milagro, F. I., Herrero, J. I., Elorz, M., Benito, A., Tobaruela-Resola, A. L., Tur, J. A., Martínez, J. A., Abete, I., et al. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.05.042 · Cited by 32

Osteosarcopenia in NAFLD/MAFLD: an underappreciated clinical problem in chronic liver disease

Musio, A., Perazza, F., Leoni, L., Stefanini, B., Dajti, E., Menozzi, R., Petroni, M. L., Colecchia, A., & Ravaioli, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087517 · Cited by 26

Efficacy of the Mediterranean diet in treating metabolic dysfunction-associated steatotic liver disease (MASLD) in children and adolescents: a systematic review and meta-analysis

Jamil, A., Chivese, T., Elshaikh, U. A. M., & Sendall, M. C. (2024) · BMC Public Health · doi:10.1186/s12889-024-19378-w · Cited by 26

The Role of Plant-Derived Natural Products in the Management of Inflammatory Bowel Disease—What Is the Clinical Evidence So Far?

Davila, M., & Papada, E. (2023) · Life · doi:10.3390/life13081703 · Cited by 26

Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis

Gairing, S. J., Schleicher, E. M., Galle, P. R., & Labenz, C. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000096 · Cited by 26

Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infections

Chen, T., Chen, G., Wang, G., Treeprasertsuk, S., Lesmana, C. R. A., Lin, H., Al‐Mahtab, M., Chawla, Y. K., Tan, S.-S., Kao, J., et al. (2024) · Hepatology International · doi:10.1007/s12072-023-10637-3 · Cited by 24

Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door

Frenette, C. T., Levy, C., & Saab, S. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07075-2 · Cited by 22

Managing cirrhosis with limited resources: perspectives from sub-Saharan Africa

Sonderup, M. W., Kamath, P. S., Awuku, Y. A., Desalegn, H., Gogela, N. A., Katsidzira, L., Tzeuton, C., Bobat, B., Kassianides, C., & Spearman, C. W. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00279-0 · Cited by 25

Emerging Treatment Options for Sarcopenia in Chronic Liver Disease

Kim, Y. (2021) · Life · doi:10.3390/life11030250 · Cited by 26

Optimizing nutrition in hepatic cirrhosis: A comprehensive assessment and care approach

Méndez-Guerrero, O., Carranza-Carrasco, A., Chi‐Cervera, L. A., Torre, A., & Navarro–Álvarez, N. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i10.1313 · Cited by 21

Nutritional Support in Acute Liver Failure

Abenavoli, L., Maurizi, V., Boccuto, L., Berardino, A. D., Giostra, N., Santori, P., Scarcella, M., Procopio, A. C., Rasetti, C., & Scarpellini, E. (2022) · Diseases · doi:10.3390/diseases10040108 · Cited by 23

The use of phase angle in patients with digestive and liver diseases

Casirati, A., Crotti, S., Raffaele, A., Caccialanza, R., & Cereda, E. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09785-6 · Cited by 21

Parenteral nutrition-associated liver injury: clinical relevance and mechanistic insights

Mihajlovic, M., Rosseel, Z., Waele, E. D., & Vinken, M. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae020 · Cited by 23

Nutritional Support for Liver Diseases

Jamioł-Milc, D., Gudan, A., Kaźmierczak-Siedlecka, K., Hołowko, J., Maciejewska, D., Janda, K., & Stachowska, E. (2023) · Nutrients · doi:10.3390/nu15163640 · Cited by 23

Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH)

Sebastiani, G., Patel, K., Ratziu, V., Feld, J. J., Neuschwander‐Tetri, B. A., Pinzani, M., Petta, S., Berzigotti, A., Metrakos, P. P., Shoukry, N. H., et al. (2021) · Canadian Liver Journal · doi:10.3138/canlivj-2021-0030 · Cited by 20

Comparison of GLIM, SGA, PG-SGA, and PNI in diagnosing malnutrition among hepatobiliary-pancreatic surgery patients

Zhou, L., Fu, J., Ding, Z., Jin, K., Wu, R., & Ye, L. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1116243 · Cited by 19

Sarcopenia in chronic viral hepatitis: From concept to clinical relevance

Coelho, M. P. P., de Castro, P. A. S. V., de Vries, T. P., Colosimo, E. A., Bezerra, J. M. T., Rocha, G. A., & Silva, L. D. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i5.649 · Cited by 19

French guidelines on TIPS : Indications and modalities

Larrue, H., Allaire, M., Weil, D., Barge, S., Thabut, D., Payancé, A., Moga, L., Jézequel, C., Artru, F., Archambeaud, I., et al. (2024) · Liver International · doi:10.1111/liv.15976 · Cited by 19

Nutritional gap after transfer from the intensive care unit to a general ward – A retrospective quality assurance study

Knudsen, A. W., Hansen, S. M., Thomsen, T., Knudsen, H., & Munk, T. (2024) · Australian Critical Care · doi:10.1016/j.aucc.2024.07.083 · Cited by 19

Recommendations for nutritional assessment across clinical practice guidelines: A scoping review

Soriano‐Moreno, D. R., Dolores-Maldonado, G. K., Benites-Bullón, A., Ccami‐Bernal, F., Fernandez‐Guzman, D., Esparza–Varas, A. L., Caira‐Chuquineyra, B., & Taype-Rondán, Á. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.04.023 · Cited by 18

Nutritional Strategies to Manage Malnutrition and Sarcopenia following Liver Transplantation: A Narrative Review

Trigui, A., Rose, C. F., & Bémeur, C. (2023) · Nutrients · doi:10.3390/nu15040903 · Cited by 19

Pathophysiological-Based Nutritional Interventions in Cirrhotic Patients with Sarcopenic Obesity: A State-of-the-Art Narrative Review

Santangeli, E., Abbati, C., Chen, R., di Carlo, A., Leoni, S., Piscaglia, F., & Ferri, S. (2024) · Nutrients · doi:10.3390/nu16030427 · Cited by 21

Celiac Disease, Gluten-Free Diet and Metabolic Dysfunction-Associated Steatotic Liver Disease

Cazac, G.-D., Mihai, B. M., Ștefănescu, G., Gîlcă-Blanariu, G.-E., Mihai, C., Grigorescu, E.-D., Onofriescu, A., & Lăcătușu, C.-M. (2024) · Nutrients · doi:10.3390/nu16132008 · Cited by 18

Higher Adherence to the Mediterranean Diet Is Associated with a Lower Risk of Steatotic, Alcohol-Related, and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Retrospective Analysis

Lee, J. H., Kim, S., Lee, Y., Kwon, Y., & Lee, J. (2024) · Nutrients · doi:10.3390/nu16203551 · Cited by 20

Malnutrition is highly prevalent in hospitalized cirrhotic patients and associates with a poor outcome

Dumont, C., Wuestenberghs, F., Lanthier, N., Piessevaux, H. H., & Dahlqvist, G. (2022) · Acta gastro-enterologica belgica · doi:10.51821/85.2.9016 · Cited by 21

Safety of treating acute liver injury and failure

García‐Cortés, M., Ortega‐Alonso, A., & Andrade, R. J. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1955854 · Cited by 17

Xylitol improves antioxidant, purinergic and cholinergic dysfunction, and lipid metabolic homeostasis in hepatic injury in type 2 diabetic rats

Msomi, N. Z., Erukainure, O. L., Salau, V. F., Olofinsan, K. A., & Islam, M. S. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14040 · Cited by 17

Mechanisms of sarcopenia in liver cirrhosis and the role of myokines

Geladari, E. V. (2023) · Annals of Gastroenterology · doi:10.20524/aog.2023.0804 · Cited by 19

Detection of Sarcopenia in Patients with Liver Cirrhosis Using the Bioelectrical Impedance Analysis

Božić, D., Grgurević, I., Mamic, B., Čapkun, V., Bilandzic-Ivisic, J., Ivanović, T., Božić, I., Žaja, I., Podrug, K., Puljiz, Ž., et al. (2023) · Nutrients · doi:10.3390/nu15153335 · Cited by 17

Review article: Evaluation and care of the critically ill patient with cirrhosis

Košuta, I., Premkumar, M., & Reddy, K. R. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18016 · Cited by 19

Impact of Liver and Pancreas Diseases on Nutritional Status

Cañamares‐Orbís, P., Monterde, V. B., Gabarda, O. S., Deza, D. C., García‐Rayado, G., Cortés, L., & Luè, A. (2021) · Nutrients · doi:10.3390/nu13051650 · Cited by 17

The role of bile acid metabolism in bone and muscle: from analytics to mechanisms

Herrmann, M., Blanco, G. R., Balasso, M., Sobolewska, K., Semeraro, M. D., Alonso, N., & Herrmann, W. (2024) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2024.2323132 · Cited by 17

A Gedunin-Type Limonoid, 7-Deacetoxy-7-Oxogedunin, from Andiroba (Carapa guianensis Aublet) Reduced Intracellular Triglyceride Content and Enhanced Autophagy in HepG2 Cells

Nagatomo, A., Ninomiya, K., Marumoto, S., Sakai, C., Watanabe, S., Ishikawa, W., Manse, Y., Kikuchi, T., Yamada, T., Tanaka, R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113141 · Cited by 17

Chinese guidelines on the management of ascites in cirrhosis

Xu, X., Ding, H., Jia, J., Wei, L., Duan, Z., Tang, C., Linghu, E., Nan, Y., Han, Y., Xu, J., et al. (2024) · Hepatology International · doi:10.1007/s12072-024-10697-z · Cited by 16

Low Levels of Serum Zinc Associate with Malnutrition Risk Assessed by the Royal Free Hospital-Nutritional Prioritizing Tool in Cirrhosis

Yang, W., Wang, X., Yu, Z., Li, C., Sun, M., Li, Y., Hui, Y., Guo, G., Fan, X., Jiang, K., et al. (2021) · Biological Trace Element Research · doi:10.1007/s12011-021-03033-1 · Cited by 16

Liver Decompensation after Bariatric Surgery in the Absence of Cirrhosis

Berg, P. V., Ulaj, A., de Broqueville, G., de Vos, M., Delire, B., Hainaut, P., Thissen, J., Stärkel, P., Komuta, M., Henry, P., et al. (2022) · Obesity Surgery · doi:10.1007/s11695-022-05930-3 · Cited by 16

Sarcopenic diabetes is an under-recognized and unmet clinical priority. A call for action from the European Society for Clinical Nutrition and Metabolism and the Diabetes Nutrition Study Group

Barazzoni, R., Sievenpiper, J. L., Genton, L., Kendall, C. W. C., Ballesteros-Pomar, M. D., Giosuè, A., Boirie‌, Y., Chiavaroli, L., Cederholm, T., Aas, A., et al. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.10.007 · Cited by 16

Sarcopenia in end-stage liver disease and after liver transplantation

Leunis, S., Vandecruys, M., Craenenbroeck, A. H. V., Cornelissen, V., Bogaerts, S., Smet, S. D., & Monbaliu, D. R. L. (2023) · Acta gastro-enterologica belgica · doi:10.51821/86.2.11412 · Cited by 16

Diagnostic and Prognostic Value of Hyperammonemia in Patients with Liver Cirrhosis, Hepatic Encephalopathy, and Sarcopenia (Experts’ Agreement)

Nadinskaia, M. Y., Maevskaya, M. V., Бакулин, И. Г., Николаевна, Б. Е., Bueverov, A. O., Жаркова, М. С., Оковитый, С. В., Ostrovskaya, A. S., Александровна, Г. К., & Ivashkin, V. T. (2024) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2024-34-1-85-100 · Cited by 15

A Systematic Review of the Twelve Most Popular Bean Varieties, Highlighting Their Potential as Functional Foods Based on the Health Benefits Derived from Their Nutritional Profiles, Focused on Non-Communicable Diseases

Dimopoulou, M., Vareltzis, P. K., & Gortzi, O. (2024) · Applied Sciences · doi:10.3390/app142210215 · Cited by 16

Nutrition in Liver Disease – A Review

Hepburn, C., & Roenn, N. V. (2023) · Current Gastroenterology Reports · doi:10.1007/s11894-023-00887-4 · Cited by 15

The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial

Hansen, J. K., Israelsen, M. E., Nishijima, S., Stinson, S. E., Andersen, P., Johansen, S., Hansen, C. D., Brol, M. J., Klein, S., Schierwagen, R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60755-9 · Cited by 14

Exercise and nutrition interventions for sarcopenia in cirrhosis: a systematic review and network meta-analysis of randomized controlled trials

Kittiprachakul, S., Maung, S. T., Poorirerngpoom, N., Srinawakul, A., Numpaisarn, M., Tiyarattanachai, T., Somlaw, N., Kulaputana, O., Ananchuensook, P., Phannajit, J., et al. (2025) · European Journal of Clinical Nutrition · doi:10.1038/s41430-025-01642-w · Cited by 16

Nutritional Management Guidelines for Sarcopenia and Frailty 2025

Kuzuya, M., Kanno, Y., Arai, H., Nishiguchi, S., Iijima, K., Umegaki, H., Satake, S., Satô, S., Shinmura, K., Sugimoto, K., et al. (2025) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.70275 · Cited by 17

British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis – part 2: decompensated cirrhosis

Mansour, D., Masson, S., Corless, L., Douds, A. C., Shawcross, D. L., Johnson, J. L., Leithead, J., Heneghan, M. A., Rahim, M. N., Tripathi, D., et al. (2023) · Frontline Gastroenterology · doi:10.1136/flgastro-2023-102431 · Cited by 14

Sarcopenia Worsening One Month after Transarterial Radioembolization Predicts Progressive Disease in Patients with Advanced Hepatocellular Carcinoma

Vallati, G. E., Trobiani, C., Teodoli, L., Lai, Q., Cappelli, F., Ungania, S., Catalano, C., & Lucatelli, P. (2021) · Biology · doi:10.3390/biology10080728 · Cited by 14

From Listing to Recovery: A Review of Nutritional Status Assessment and Management in Liver Transplant Patients

Ravaioli, F., Maria, N. D., Marco, L. D., Pivetti, A., Casciola, R., Ceraso, C., Frassanito, G., Pambianco, M., Pecchini, M., Sicuro, C., et al. (2023) · Nutrients · doi:10.3390/nu15122778 · Cited by 16

COVID-19 and liver dysfunction: What nutritionists need to know

Wang, M., Yu, X.-L., Zhou, L., Si, H.-M., Hui, J.-F., Hou, D., Li, W.-P., & Yang, J. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i15.1526 · Cited by 13

Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver Cirrhosis

Kaps, L., Lukac, L., Michel, M. S., Kremer, W. M., Hilscher, M., Gairing, S. J., Galle, P. R., Schattenberg, J. M., Wörns, M., Nagel, M. C., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12051069 · Cited by 13

Diagnosis and Pathogenesis of Sarcopenia in Chronic Liver Disease Using Liver Magnetic Resonance Imaging

Nakamura, A., Yoshimura, T., Sato, T., & Ichikawa, T. (2022) · Cureus · doi:10.7759/cureus.24676 · Cited by 13

An update on the genetics of alcoholic liver disease

Vishnubhotla, R., Kulkarni, A. V., Sharma, M., Rao, P. N., & Reddy, D. N. (2022) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2022.1030399 · Cited by 13

Clinical and biomarker assessment of frailty in liver transplantation

Ayorinde, T., Panayotova, G. G., Sharma, A., & Lunsford, K. E. (2021) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000911 · Cited by 13

Usefulness of nutritional therapy recommended in the Japanese Society of Gastroenterology/Japan Society of Hepatology evidence-based clinical practice guidelines for liver cirrhosis 2020

Hanai, T., Nishimura, K., Miwa, T., Maeda, T., Ogiso, Y., Imai, K., Suetsugu, A., Takai, K., & Shimizu, M. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01821-z · Cited by 12

Role of Branched-Chain Amino Acids and Their Derivative β-Hydroxy-β-Methylbutyrate in Liver Cirrhosis

Espina, S., Sanz‐París, A., Monterde, V. B., Deza, D. C., & Arbonés-Mainar, J. M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247337 · Cited by 12

The European Society for Clinical Nutrition and Metabolism practical guideline: Clinical nutrition in liver disease

Bischoff, S. C., Bernal, W. E., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., Plauth, M., Скрипник, І. М., & Shvets, O. (2021) · Modern Gastroenterology · doi:10.30978/mg-2021-1-59

The European Society for Clinical Nutrition and Metabolism practical guideline: Clinical nutrition in liver disease. Part 2

Bischoff, S. C., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., Plauth, M., Skrypnyk, I., & Shvets, O. (2021) · Modern Gastroenterology · doi:10.30978/mg-2021-2-28 · Cited by 5

Interpretation of European Society for Clinical Nutrition and Metabolism practical guideline: Clinical nutrition in liver disease (2020)

Dandan, J. (2021) · DOAJ (DOAJ: Directory of Open Access Journals)

ESPEN guideline on clinical nutrition in liver disease

Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., & Bischoff, S. C. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.12.022 · Cited by 674

《2020年欧洲临床营养和代谢学会实践指南：肝病的临床营养》解读

贾丹丹, 朱桂英, 廖诗瑶, 章慧, Guo, H. M., 杨莉莉, & 王长淼 (2021) · Chinese Journal of Clinical Hepatology · doi:10.3969/j.issn.1001-5256.2021.07.015